|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/22 | (2006.01) |
| A61K 31/66 | (2013.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61K 31/66 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| C07F 9/50 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Patento numeris | 3713559 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18880479.3 |
| Europos patento paraiškos padavimo data | 2018-11-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-09-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/062174 |
| Data | 2018-11-21 |
| (87) | Numeris | WO 2019/104115 |
| Data | 2019-05-31 |
| (30) | Numeris | Data | Šalis |
| 201762590432 P | 2017-11-24 | US |
| (72) |
LISANTI, Michael, P. , US
SOTGIA, Federica , CA
|
| (73) |
Lunella Biotech, Inc. ,
145 Richmond Road, Ottawa, ON K1Z 1A1,
CA
|
| (54) | TRIPHENYLPHOSPHONIUM COMPOUNDS FOR USE IN PREVENTING OR TREATING TUMOR RECURRENCE, METASTASIS AND RADIOTHERAPY RESISTANCE OR FOR TREATING CANCER |
| TRIPHENYLPHOSPHONIUM COMPOUNDS FOR USE IN PREVENTING OR TREATING TUMOR RECURRENCE, METASTASIS AND RADIOTHERAPY RESISTANCE OR FOR TREATING CANCER |